Andera Partners | WebDisclosure

PRESS RELEASE

published on 10/22/2025 at 09:00, 8 months 22 days ago

Ipsen to acquire ImCheck Therapeutics, in Andera Partners’ portfolio, expanding its leadership in oncology, strengthening its pipeline
Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology by acquiring all shares of ImCheck. Anticipated acquisition focuses on ICT01 program for acute myeloid leukemia. Transaction details and advisors highlighted

Acquisition Oncology Ipsen ImCheck Therapeutics ICT01
BRIEF

published on 10/16/2025 at 11:10, 8 months 28 days ago

Andera Partners co-dirige une levée de fonds de série A de 105 millions d'euros pour Adcytherix

Investissement Andera Partners Traitements Contre Le Cancer Adcytherix BioDiscovery 7
BRIEF

published on 10/16/2025 at 11:10, 8 months 28 days ago

Andera Partners Co-Leads €105 Million Series A for Adcytherix

Investment Andera Partners Cancer Treatments Adcytherix BioDiscovery 7
PRESS RELEASE

published on 10/16/2025 at 11:05, 8 months 28 days ago

Andera Partners co-leads €105 million Series A round for Adcytherix, its first investment from the BioDiscovery 7 fund
Andera Partners co-leads €105 million Series A funding round for Adcytherix, marking the first investment from BioDiscovery 7 fund to advance novel ADC programs for cancer treatment

Andera Partners ADC Series A Adcytherix BioDiscovery 7
BRIEF

published on 10/15/2025 at 11:15, 8 months 29 days ago

Andera Partners Commits to Tubulis' €308 Million Series C for ADC Development

Series C Financing Andera Partners Tubulis ADC Development Clinical Expansion
BRIEF

published on 10/15/2025 at 11:15, 8 months 29 days ago

Andera Partners s'engage dans la série C de Tubulis, d'un montant de 308 millions d'euros, pour le développement d'ADC

Andera Partners Tubulis Développement ADC Financement De Série C Expansion Clinique
PRESS RELEASE

published on 10/15/2025 at 11:10, 8 months 29 days ago

Andera Partners Reinvests in Tubulis’ €308 million Series C to Accelerate Clinical Development of Lead ADC Candidate TUB-040 and Expand Pipeline
Andera Partners reinvests in Tubulis' €308 million Series C financing to accelerate clinical development of lead ADC candidate TUB-040 and expand pipeline, attracting top-tier investors

Series C Financing Clinical Development Andera Partners Tubulis ADC Candidate
BRIEF

published on 06/12/2025 at 10:05, 1 year 1 month ago

Andera Partners Expands Mezzanine Sponsorless Strategy with Key Appointments

Andera Partners Strategic Appointments European Markets International Development Mezzanine Sponsorless
BRIEF

published on 06/12/2025 at 10:05, 1 year 1 month ago

Andera Partners élargit sa stratégie de financement mezzanine sans sponsor avec des nominations clés

Développement International Andera Partners Marchés Européens Nominations Stratégiques Mezzanine Sans Sponsor
PRESS RELEASE

published on 06/12/2025 at 10:00, 1 year 1 month ago

Andera Partners increases international development of its Mezzanine Sponsorless business and announces two strategic appointments
Andera Partners expands Mezzanine Sponsorless business internationally with two strategic appointments, reinforcing European private financing strategy

Andera Partners Strategic Appointments International Development Mezzanine Sponsorless Private Financing

Published on 07/14/2026 at 01:45, 2 hours 44 minutes ago

Arctic Fox Lithium Approved for Trading on the OTCQB Venture Market and Announces DTC Eligibility
Published on 07/14/2026 at 00:01, 4 hours 28 minutes ago

Captor Capital Announces Delay in its Annual Filings
Published on 07/13/2026 at 23:10, 5 hours 19 minutes ago

Galaxy Ventures Inc. Announces Director Resignation
Published on 07/13/2026 at 21:35, 6 hours 54 minutes ago

ATHA Energy Announces Corporate Activities Update
Published on 07/13/2026 at 20:00, 8 hours 29 minutes ago

IBC Announces Share-Based Compensation to Directors

View all ACCESSWIRE

Published on 07/13/2026 at 22:30, 5 hours 59 minutes ago

Half-year 2026 Results Media and Investor Conference Call and Webcast
Published on 07/13/2026 at 21:20, 7 hours 9 minutes ago

Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 21:17, 7 hours 11 minutes ago

EQS-Adhoc: Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 20:48, 7 hours 41 minutes ago

EQS-Adhoc: Gateway Real Estate AG: Forecast for the financial year 2026
Published on 07/13/2026 at 20:23, 8 hours 6 minutes ago

EQS-Adhoc: TRATON SE: Preliminary operating result for Q2 2026 exceeds market expectations

View all EQS

Published on 07/13/2026 at 18:00, 10 hours 29 minutes ago

CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 10 hours 29 minutes ago

PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 10 hours 29 minutes ago

THERMADOR GROUPE : 2026 half-year turnover
Published on 07/13/2026 at 18:00, 10 hours 29 minutes ago

THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026
Published on 07/13/2026 at 17:45, 10 hours 44 minutes ago

Weekly share buyback

View all LES ECHOS COMFI WIRE

News